Longevity & AgingResearch PaperOpen Access

How Systemic Aging Drives Heart Failure Through Multiple Molecular Pathways

Comprehensive review reveals how aging across multiple organ systems contributes to heart failure through interconnected molecular mechanisms.

Tuesday, March 31, 2026 0 views
Published in ESC Heart Fail0 supporting45 total citations
Aging heart muscle cells with visible mitochondrial damage, surrounded by inflammatory molecules and senescent cells, contrasted with healthy cells

Summary

This comprehensive review examines how systemic aging drives heart failure through multiple interconnected pathways. The authors detail how cardiac aging involves genomic stress, epigenetic changes, oxidative damage, and cellular senescence. Vascular aging contributes through endothelial dysfunction and arterial stiffness. Metabolic aging causes insulin resistance and mitochondrial dysfunction. Chronic inflammation accelerates cardiac decline. Age-related comorbidities like diabetes and kidney disease further compound the problem. The review highlights promising interventions including exercise, dietary modifications, and emerging therapeutics targeting senescence, inflammation, and metabolic dysfunction.

Detailed Summary

Heart failure increasingly affects aging populations, with systemic aging processes contributing to cardiac dysfunction through multiple interconnected mechanisms. This comprehensive review by Fang et al. examines how aging across different organ systems collectively drives heart failure development.

The authors detail how cardiac aging involves several key processes. Genomic stress accumulates through DNA mutations, particularly in mitochondria, compromising cellular function. Epigenetic changes alter gene expression patterns, while oxidative stress damages cellular components. Autophagy becomes impaired, cellular senescence increases, and regenerative capacity declines. These changes manifest as left ventricular hypertrophy, diastolic dysfunction, atrial fibrillation, and myocardial fibrosis.

Vascular aging compounds cardiac stress through endothelial dysfunction, arterial stiffness, and impaired angiogenesis. Metabolic aging drives insulin resistance, mitochondrial dysfunction, and lipid accumulation in heart muscle cells. Chronic low-grade inflammation, termed "inflammaging," promotes immune cell infiltration and tissue damage. Age-related comorbidities including coronary artery disease, hypertension, diabetes, and chronic kidney disease create additional cardiac burden.

The review emphasizes that aging is increasingly viewed as a modifiable process rather than inevitable decline. Exercise emerges as a powerful intervention, countering oxidative stress, inflammation, and senescence while promoting cardiac regeneration. Dietary approaches including plant-based diets, caloric restriction, and specific nutrient supplementation show promise. Emerging therapeutics target senescent cells (senolytics), reduce inflammation, enhance metabolism, and promote autophagy.

This work provides a framework for understanding heart failure as a consequence of systemic aging processes, opening new therapeutic avenues beyond traditional cardiac-focused treatments.

Key Findings

  • Cardiac aging involves genomic stress, epigenetic changes, oxidative damage, and cellular senescence
  • Vascular aging contributes through endothelial dysfunction and arterial stiffness
  • Metabolic aging causes insulin resistance and mitochondrial dysfunction in heart cells
  • Chronic inflammation accelerates cardiac decline and promotes heart failure
  • Exercise and dietary interventions can counter multiple aging pathways simultaneously

Methodology

This is a comprehensive narrative review synthesizing current literature on systemic aging mechanisms contributing to heart failure. The authors examined molecular pathways across cardiac, vascular, metabolic, and inflammatory systems, integrating findings from basic science and clinical studies.

Study Limitations

As a narrative review, this work synthesizes existing literature rather than presenting new experimental data. The complexity of aging processes makes it challenging to determine which interventions will be most effective in clinical practice. Long-term safety and efficacy data for many proposed anti-aging therapeutics remain limited.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.